Barclays »

Longboard Pharmaceuticals In shares owned by Barclays

Quarter-by-quarter ownership of Longboard Pharmaceuticals In (LBPH) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Longboard Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Longboard Pharmaceuticals In held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Longboard Pharmaceuticals In by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $129k 21k 6.02
2023-09-30 $16k 2.8k 5.74
2023-06-30 $23k 3.1k 7.36

More positions owned by Barclays

Invesco Qqq Tr Opt Call Option (QQQ)
SPDR S&ampP 500 ETF TR Opt Put Option (SPY)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple (AAPL)
Amazon Opt Call Option (AMZN)
Alphabet Opt Put Option (GOOGL)
NVIDIA Corporation (NVDA)
Tesla Opt Put Option (TSLA)
Meta Platforms Opt Put Option (META)
Ishares Tr Fund (HYG)
Alphabet Opt Call Option (GOOG)
Visa Opt Put Option (V)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)

View all positions for Barclays

Top funds holding Longboard Pharmaceuticals In

Cormorant Asset Management
T. Rowe Price Associates
Ikarian Capital
Point72 Asset Management
Vanguard Group
Jpmorgan Chase & Co
Jennison Associates
TD Asset Management
Schonfeld Strategic Advisors
Bank of New York Mellon
Charles Schwab Investment Management
Walleye Trading Advisors
Dimensional Fund Advisors
Jacobs Levy Equity Management
Laurion Capital Management

View all funds holding Longboard Pharmaceuticals In